Earnings watch · TLX · Healthcare

Telix Pharmaceuticals Limited (TLX) approaches earnings with momentum split

The radiopharmaceuticals developer reports on June 18 with a recent weekly gain set against a weaker four-week tape.

Telix Pharmaceuticals Limited
Latest9.560 USD
1W move2.8%
Volume1.1x
TrendActive
Biotechnology market data screen and radiopharmaceutical lab equipment representing Telix Pharmaceuticals before earnings.

Market update

What happened

Telix Pharmaceuticals Limited (TLX) closed at 9.560 USD in the latest weekly market data ahead of its June 18 earnings date, with the stock up 2.8% for the week but down 9.5% over four weeks.

The setup is mixed. The trend signal remains active and twelve-week performance is positive at 9.3%, while Relative Strength is negative at -21.3 and Market Dynamics at 0.44 offers only limited confirmation. Volume was modestly above the 13-week average at 1.09x.

The chart is weekly price path over 52 weeks, so it frames broader positioning rather than live intraday trading. The earnings calendar shows a fiscal-quarter estimate of -0.01 USD for the period ending March 31.

Continue your research

Explore TLX across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Short interestReview short positioning, crowding and possible squeeze risk.

TLX coverage

Evidence context